View in EDS PDF Full Text

A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer.

Saved in:
Bibliographic Details
Title: A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer.
Authors: Gurule NJ; Department of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., McCoach CE; Department of Medicine and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA., Hinz TK; Department of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Merrick DT; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Van Bokhoven A; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Kim J; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Patil T; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Calhoun J; Department of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Nemenoff RA; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Tan AC; Moffitt Cancer Center, Tampa, FL, USA., Doebele RC; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Robert.Doebele@cuanschutz.edu., Heasley LE; Department of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Lynn.Heasley@cuanschutz.edu.; Eastern Colorado VA Healthcare System, Rocky Mountain Regional VA Medical Center, Aurora, CO, USA. Lynn.Heasley@cuanschutz.edu.
Source: NPJ precision oncology [NPJ Precis Oncol] 2021 May 17; Vol. 5 (1), pp. 41. Date of Electronic Publication: 2021 May 17.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34001994
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gurule+NJ%22">Gurule NJ</searchLink>; Department of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22McCoach+CE%22">McCoach CE</searchLink>; Department of Medicine and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hinz+TK%22">Hinz TK</searchLink>; Department of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Merrick+DT%22">Merrick DT</searchLink>; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Van+Bokhoven+A%22">Van Bokhoven A</searchLink>; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Kim+J%22">Kim J</searchLink>; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Patil+T%22">Patil T</searchLink>; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Calhoun+J%22">Calhoun J</searchLink>; Department of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Nemenoff+RA%22">Nemenoff RA</searchLink>; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Tan+AC%22">Tan AC</searchLink>; Moffitt Cancer Center, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Doebele+RC%22">Doebele RC</searchLink>; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Robert.Doebele@cuanschutz.edu.<br /><searchLink fieldCode="AU" term="%22Heasley+LE%22">Heasley LE</searchLink>; Department of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Lynn.Heasley@cuanschutz.edu.; Eastern Colorado VA Healthcare System, Rocky Mountain Regional VA Medical Center, Aurora, CO, USA. Lynn.Heasley@cuanschutz.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101708166%22">NPJ precision oncology</searchLink> [NPJ Precis Oncol] 2021 May 17; Vol. 5 (1), pp. 41. <i>Date of Electronic Publication: </i>2021 May 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101708166 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2397-768X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222397768X%22">2397768X </searchLink><i>NLM ISO Abbreviation: </i>NPJ Precis Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34001994
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41698-021-00181-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 41
    Titles:
      – TitleFull: A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gurule NJ
      – PersonEntity:
          Name:
            NameFull: McCoach CE
      – PersonEntity:
          Name:
            NameFull: Hinz TK
      – PersonEntity:
          Name:
            NameFull: Merrick DT
      – PersonEntity:
          Name:
            NameFull: Van Bokhoven A
      – PersonEntity:
          Name:
            NameFull: Kim J
      – PersonEntity:
          Name:
            NameFull: Patil T
      – PersonEntity:
          Name:
            NameFull: Calhoun J
      – PersonEntity:
          Name:
            NameFull: Nemenoff RA
      – PersonEntity:
          Name:
            NameFull: Tan AC
      – PersonEntity:
          Name:
            NameFull: Doebele RC
      – PersonEntity:
          Name:
            NameFull: Heasley LE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 05
              Text: 2021 May 17
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 2397-768X
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ precision oncology
              Type: main
ResultId 1